Activist 13D/13G Filings - ORBIMED CAPITAL LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-14
6:27 pm
Purchase		13GSI-BONE Inc.
SIBN		ORBIMED CAPITAL LLC3,249,500
7.800%		944,200increase
(+40.96%)		View
2023-02-14
4:45 pm
Sale		13GMILESTONE PHARMACEUTICALS INC
MIST		ORBIMED CAPITAL LLC0
0.000%		-2,583,821decrease
(Position Closed)		View
2023-02-14
4:14 pm
Sale		13GCYBIN INC.
CYBN		ORBIMED CAPITAL LLC6,153,299
3.700%		-5,138,001decrease
(-45.50%)		View
2022-02-11
4:44 pm
Purchase		13GSI-BONE Inc.
SIBN		ORBIMED CAPITAL LLC2,305,300
6.900%		2,305,300increase
(New Position)		View
2022-02-11
4:32 pm
Purchase		13GMILESTONE PHARMACEUTICALS INC
MIST		ORBIMED CAPITAL LLC2,583,821
8.700%		90,712increase
(+3.64%)		View
2022-02-11
4:20 pm
Purchase		13GCYBIN INC.
CYBN		ORBIMED CAPITAL LLC11,291,300
7.000%		11,291,300increase
(New Position)		View
2022-02-11
4:15 pm
Sale		13GAPTOSE BIOSCIENCES INC NO
APTO		ORBIMED CAPITAL LLC0
0.000%		-8,030,000decrease
(Position Closed)		View
2021-02-12
5:03 pm
Purchase		13GMILESTONE PHARMACEUTICALS INC
MIST		ORBIMED CAPITAL LLC2,493,109
8.360%		2,493,109increase
(New Position)		View
2021-02-12
4:42 pm
Purchase		13GAPTOSE BIOSCIENCES INC NO
APTO		ORBIMED CAPITAL LLC8,030,000
9.040%		8,030,000increase
(New Position)		View
2020-02-14
12:00 pm
Sale		13GFoamix Pharmaceuticals Ltd.
FOMX		ORBIMED CAPITAL LLC2,577,982
4.170%		-2,617,348decrease
(-50.38%)		View